Welcome, Guest
Username: Password: Remember me
General
  • Page:
  • 1

TOPIC: Cytori: Why This Undervalued Cell-Therapy Biotech

Cytori: Why This Undervalued Cell-Therapy Biotech 25 Nov 2014 23:21 #2794

  • StevieRay
  • StevieRay's Avatar Topic Author
  • Offline
  • Junior Boarder
  • Junior Boarder
  • Posts: 36
  • Thank you received: 7
New Seeking Alpha Writeup:
seekingalpha.com/article/2711865-cytori-why-this-undervalued-cell-therapy-biotech-is-a-buy

Maybe the worm is about to turn.... :happy:

Please Log in or Create an account to join the conversation.

Cytori: Why This Undervalued Cell-Therapy Biotech 26 Nov 2014 02:37 #2795

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3337
  • Thank you received: 1115
Article is pretty factual- so can be recommended... :winky:

Those facts have been covered here more extensively so just the chart here :



and related text:

A look at the weekly chart of Cytori shows just how far, and rapidly it has fallen in 2014 since peaking over 3$ in February. With a weekly RSI of 16, the stock is well oversold and has been so for a few months now. Other markers including the MACD, Stochastics and Money Flow Index indicate that this is likely a stock that is currently in the process (albeit a lengthy one) of bottoming out. Technically, the stock has ample upside room from current levels.

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Cytori: Why This Undervalued Cell-Therapy Biotech 26 Nov 2014 09:47 #2798

  • myownhedgefund
  • myownhedgefund's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2825
  • Thank you received: 202
Fas...some technicals from you ? :grin:

Too bad the article is using dated material as technicals has indeed improved greatly and thus we are now at $ 0.43 vs the $ 0.41 in the charts provided from few weeks ago.

Tax selling will be over at year end but the vote on Jan 6 may also be a event effecting the PPS and then ATHENA data.
Otherwise its the R/S for sure....of course I believe its unavoidable anyway without a major partner deal. Clock is ticking !!!

Small correction...weekly data is being used vs daily data in the charts provided....so is not dated material.

Please Log in or Create an account to join the conversation.

Cytori: Why This Undervalued Cell-Therapy Biotech 26 Nov 2014 10:25 #2800

  • fas
  • fas's Avatar
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3337
  • Thank you received: 1115
No no Hedge... I stay away from technicals. Thats why I copied the stuff from the article - simply -AS A SERVICE TO ANYONE ELSE WHO APPRECIATES THAT STUFF... :grin: :winky:

I just looked at my charts on "the its stock" section of the page.

Here I had technical analysis from a German Guru who´s own stock (which I had for ages too) is one of the shining stars of biotech.

Morphosys. :whistle:

Oh well- I love the underdog apparently.. :cool: :KO: :bang:

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Cytori: Why This Undervalued Cell-Therapy Biotech 29 Nov 2014 14:07 #2823

  • franshei
  • franshei's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 790
  • Thank you received: 103
I read this Seeking Alpha article only a day or so ago. It looks like a DOV style write up.

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.090 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites